NGM Biopharmaceuticals NGM
$ 1.54
0.0%
Annual report 2023
added 03-11-2024
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. David Woodhouse |
Employees in the company |
186 |
Shares |
82.5 M |
Market Cap[1] |
$ 127 M |
EBITDA (LTM) |
$ -168 M |
P/E (LTM) |
-0.4 |
P/S (LTM) |
5.26 |
EPS (LTM) |
-1.98 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.